Internal Medicine Doctors in Chippewa Falls, WI Accepting Medicare

5 Internal Medicine doctors found. Showing 1 - 5

Dr. Edward L. Ebert, DO Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2655 Cty Hwy I, Chippewa Falls, WI 54729 Phone: 715-726-4200

Fern Springs, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2909 E Park Ave, Chippewa Falls, WI 54729 Phone: 715-720-2850

Dr. James Floyd Herron, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 475 Chippewa Mall Dr Ste 418, Chippewa Falls, WI 54729 Phone: 715-720-3780    Fax: 715-720-2322

Mrs. Margaret Ann Khan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2820 E Park Ave, Chippewa Falls, WI 54729 Phone: 715-723-5542    Fax: 715-723-7957

Steven Q Paulson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2655 Cty Hwy I, Chippewa Falls, WI 54729 Phone: 715-723-8827

News Archive

Prostatic artery embolization improves sleep, quality of life for men with enlarged prostates

An innovative interventional radiology treatment for men with enlarged prostates decreases the number of times they wake to urinate in the night, according to research presented at the Society of Interventional Radiology's 2016 Annual Scientific Meeting. Researchers said the majority of men with enlarged prostates and lower urinary tract symptoms reported better sleep that resulted in an improved quality of life after they underwent a treatment called prostatic artery embolization (PAE).

Resverlogix completes RVX-208 Phase 2b trial on CVD

Resverlogix Corp. is pleased to announce that dosing in SUSTAIN, a Phase 2b clinical trial to assess lipid trends and safety of RVX-208, has been completed on schedule.

Protecting children from gun violence

Pediatric leaders and researchers will tackle the complex and often politically charged subject of gun violence during a special symposium on Saturday, May 4, at the Pediatric Academic Societies annual meeting in Washington, DC.

Gilead Sciences receives FDA approval for Stribild to treat HIV-1 infection

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Stribild (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), a complete once-daily single tablet regimen for HIV-1 infection for treatment-naïve adults.

Read more Medical News

› Verified 7 days ago